DENOVO-RBC

Project reference: 641093

Funded under:

H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Developing Novel and Optimal Additive Solutions for Red Blood Cells

From 2015-03-01 to 2016-08-31, closed project

Project details

Total cost: EUR 150 000

EU contribution: EUR 150 000

Coordinated in: Iceland

Topic(s):

ERC-PoC-2014 - ERC Proof of Concept Grant

Call for proposal:

ERC-2014-PoCSee other projects for this call

Funding scheme:

ERC-POC - Proof of Concept Grant

Objective

"The research conducted in SYSTEM_US (ERC Advanced Grant #232816) has led to the discovery of valuable biomarkers for the quality of red blood cells (RBCs) in standard blood bank storage conditions. Using a combination of systems biology and metabolomics, this discovery will lead to the development of novel RBC storage technologies including additive solutions and diagnostics. These technologies will become valuable assets in the form of intellectual property to large transfusion medicine companies and will save thousands of lives over the coming decades. This proposal covers the needs to fully define the market and NPV of the developing technology, fully define the regulatory and clinical path of product approval, file for patents to protect the intellectual property, conduct necessary validation experiments, and continue to develop relations with industry contacts."

Expand / Contract(-)

Host Institution

HASKOLI ISLANDS

Iceland

Beneficiaries

HASKOLI ISLANDS

Iceland

To know more

http://erc.europa.eu/

Þú ert að nota: brimir.rhi.hi.is